发明名称 |
ANTI-AMYLOIDOGENIC AGENTS |
摘要 |
A method for treating a human amyloid disease which includes administering a pharmaceutically effective amount of a composition to form an amyloidogenic protein-stabilizing aryl compound. These compounds include an amyloidogenic protein-stabilizing compound; said amyloidogenic protein-stabilizing compound is a nonsteroidal anti-inflammatory compound selected from 2,4,6-triiodophenol, mefenamic acid, diflunisal, meclofenamic acid, milrinone, ethacrynic acid, diclofenac, indomethacin, sulindac, fenclofenac, fenoprofen, flufenamic acid, and EMD 21388 (Merck), (i.e., 2-(3,5-dibromo-4-hydroxyphenyl)-4H-6-hydroxy-1-benzopyran-4-one see structure (I)).
|
申请公布号 |
WO9827972(A8) |
申请公布日期 |
2001.05.31 |
申请号 |
WO1997US24181 |
申请日期 |
1997.12.23 |
申请人 |
TEXAS A & M UNIVERSITY;DE GUZMAN MIROV, GRETA, J.;KELLY, JEFFERY, W.;LAI, ZHIHONG;LASHUEL, HILAL, A.;PETERSON, SCOTT, A. |
发明人 |
DE GUZMAN MIROV, GRETA, J.;KELLY, JEFFERY, W.;LAI, ZHIHONG;LASHUEL, HILAL, A.;PETERSON, SCOTT, A. |
分类号 |
A61K31/055;A61K31/192;A61K31/196;A61K31/351;A61K31/405;A61K31/444;A61K47/48;(IPC1-7):A61K31/405 |
主分类号 |
A61K31/055 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|